Omalizumab-Associated Steatohepatitis
Actas Dermosifiliogr. 2023 Jul-Aug;114(7):T650-T651.
doi: 10.1016/j.ad.2021.10.029.
Epub 2023 Jun 8.
[Article in
English,
Spanish]
Affiliations
- 1 Dermatology and Venereology Department, Hospital de Santo António dos Capuchos, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal. Electronic address: joanafabarbosa@gmail.com.
- 2 Dermatology and Venereology Department, Hospital de Santo António dos Capuchos, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
- 3 Department of Dermatology, Hospital del Mar, Institut Mar D'Investigacions Mediques, Universitat Autònoma, Barcelona, España.
No abstract available
MeSH terms
-
Anti-Asthmatic Agents*
-
Antibodies, Monoclonal, Humanized
-
Fatty Liver*
-
Humans
-
Omalizumab / adverse effects
-
Treatment Outcome
Substances
-
Omalizumab
-
Antibodies, Monoclonal, Humanized
-
Anti-Asthmatic Agents